The global Peripheral Neuritis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Peripheral neuropathy is a syndrome caused by sensory loss, muscle weakness and atrophy, decreased tendon reflexes, and vasomotor symptoms, alone or in any combination. Of all the options for the treatment of peripheral neuritis, analgesics and local anesthetics are the first line of treatment to relieve the inflammation of peripheral nerves.
This report aims to provide a comprehensive presentation of the global market for Peripheral Neuritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Neuritis Treatment. This report contains market size and forecasts of Peripheral Neuritis Treatment in global, including the following market information:
- Global Peripheral Neuritis Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diabetic Peripheral Neuropathy (DPN) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peripheral Neuritis Treatment include Pfizer, Depomed, Novartis, Biogen, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Bristol-Myers Squibb and Baxter Healthcare, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peripheral Neuritis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peripheral Neuritis Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Peripheral Neuritis Treatment Market Segment Percentages, by Type, 2022 (%)
- Diabetic Peripheral Neuropathy (DPN)
- Chemotherapy-induced Peripheral Neuropathy (CIPN)
- Idiopathic Peripheral Neuropathy (IPN)
- Others
Global Peripheral Neuritis Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Peripheral Neuritis Treatment Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Peripheral Neuritis Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Peripheral Neuritis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Peripheral Neuritis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Peripheral Neuritis Treatment revenues share in global market, 2022 (%)
Key players include:
- Pfizer
- Depomed
- Novartis
- Biogen
- GlaxoSmithKline
- Sanofi
- Eli Lilly and Company
- Bristol-Myers Squibb
- Baxter Healthcare
- Johnson & Johnson
- Teva Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peripheral Neuritis Treatment, market overview.
Chapter 2: Global Peripheral Neuritis Treatment market size in revenue.
Chapter 3: Detailed analysis of Peripheral Neuritis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peripheral Neuritis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peripheral Neuritis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Neuritis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Neuritis Treatment Overall Market Size
2.1 Global Peripheral Neuritis Treatment Market Size: 2022 VS 2030
2.2 Global Peripheral Neuritis Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peripheral Neuritis Treatment Players in Global Market
3.2 Top Global Peripheral Neuritis Treatment Companies Ranked by Revenue
3.3 Global Peripheral Neuritis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Peripheral Neuritis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peripheral Neuritis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peripheral Neuritis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Peripheral Neuritis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Peripheral Neuritis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peripheral Neuritis Treatment Market Size Markets, 2022 & 2030
4.1.2 Diabetic Peripheral Neuropathy (DPN)
4.1.3 Chemotherapy-induced Peripheral Neuropathy (CIPN)
4.1.4 Idiopathic Peripheral Neuropathy (IPN)
4.1.5 Others
4.2 By Type - Global Peripheral Neuritis Treatment Revenue & Forecasts
4.2.1 By Type - Global Peripheral Neuritis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Peripheral Neuritis Treatment Revenue, 2024-2030
4.2.3 By Type - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripheral Neuritis Treatment Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Peripheral Neuritis Treatment Revenue & Forecasts
5.2.1 By Application - Global Peripheral Neuritis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Peripheral Neuritis Treatment Revenue, 2024-2030
5.2.3 By Application - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Peripheral Neuritis Treatment Market Size, 2022 & 2030
6.2 By Region - Global Peripheral Neuritis Treatment Revenue & Forecasts
6.2.1 By Region - Global Peripheral Neuritis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Peripheral Neuritis Treatment Revenue, 2024-2030
6.2.3 By Region - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Peripheral Neuritis Treatment Revenue, 2018-2030
6.3.2 US Peripheral Neuritis Treatment Market Size, 2018-2030
6.3.3 Canada Peripheral Neuritis Treatment Market Size, 2018-2030
6.3.4 Mexico Peripheral Neuritis Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Peripheral Neuritis Treatment Revenue, 2018-2030
6.4.2 Germany Peripheral Neuritis Treatment Market Size, 2018-2030
6.4.3 France Peripheral Neuritis Treatment Market Size, 2018-2030
6.4.4 U.K. Peripheral Neuritis Treatment Market Size, 2018-2030
6.4.5 Italy Peripheral Neuritis Treatment Market Size, 2018-2030
6.4.6 Russia Peripheral Neuritis Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Peripheral Neuritis Treatment Market Size, 2018-2030
6.4.8 Benelux Peripheral Neuritis Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Peripheral Neuritis Treatment Revenue, 2018-2030
6.5.2 China Peripheral Neuritis Treatment Market Size, 2018-2030
6.5.3 Japan Peripheral Neuritis Treatment Market Size, 2018-2030
6.5.4 South Korea Peripheral Neuritis Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Peripheral Neuritis Treatment Market Size, 2018-2030
6.5.6 India Peripheral Neuritis Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Peripheral Neuritis Treatment Revenue, 2018-2030
6.6.2 Brazil Peripheral Neuritis Treatment Market Size, 2018-2030
6.6.3 Argentina Peripheral Neuritis Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peripheral Neuritis Treatment Revenue, 2018-2030
6.7.2 Turkey Peripheral Neuritis Treatment Market Size, 2018-2030
6.7.3 Israel Peripheral Neuritis Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Peripheral Neuritis Treatment Market Size, 2018-2030
6.7.5 UAE Peripheral Neuritis Treatment Market Size, 2018-2030
7 Peripheral Neuritis Treatment Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Peripheral Neuritis Treatment Major Product Offerings
7.1.4 Pfizer Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Depomed
7.2.1 Depomed Company Summary
7.2.2 Depomed Business Overview
7.2.3 Depomed Peripheral Neuritis Treatment Major Product Offerings
7.2.4 Depomed Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.2.5 Depomed Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Peripheral Neuritis Treatment Major Product Offerings
7.3.4 Novartis Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Peripheral Neuritis Treatment Major Product Offerings
7.4.4 Biogen Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Peripheral Neuritis Treatment Major Product Offerings
7.5.4 GlaxoSmithKline Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Peripheral Neuritis Treatment Major Product Offerings
7.6.4 Sanofi Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Peripheral Neuritis Treatment Major Product Offerings
7.7.4 Eli Lilly and Company Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.7.5 Eli Lilly and Company Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Peripheral Neuritis Treatment Major Product Offerings
7.8.4 Bristol-Myers Squibb Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Baxter Healthcare
7.9.1 Baxter Healthcare Company Summary
7.9.2 Baxter Healthcare Business Overview
7.9.3 Baxter Healthcare Peripheral Neuritis Treatment Major Product Offerings
7.9.4 Baxter Healthcare Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.9.5 Baxter Healthcare Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Peripheral Neuritis Treatment Major Product Offerings
7.10.4 Johnson & Johnson Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 Teva Pharmaceuticals
7.11.1 Teva Pharmaceuticals Company Summary
7.11.2 Teva Pharmaceuticals Business Overview
7.11.3 Teva Pharmaceuticals Peripheral Neuritis Treatment Major Product Offerings
7.11.4 Teva Pharmaceuticals Peripheral Neuritis Treatment Revenue in Global Market (2018-2023)
7.11.5 Teva Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peripheral Neuritis Treatment Market Opportunities & Trends in Global Market
Table 2. Peripheral Neuritis Treatment Market Drivers in Global Market
Table 3. Peripheral Neuritis Treatment Market Restraints in Global Market
Table 4. Key Players of Peripheral Neuritis Treatment in Global Market
Table 5. Top Peripheral Neuritis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Peripheral Neuritis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Peripheral Neuritis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Peripheral Neuritis Treatment Product Type
Table 9. List of Global Tier 1 Peripheral Neuritis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peripheral Neuritis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peripheral Neuritis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Peripheral Neuritis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Peripheral Neuritis Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Peripheral Neuritis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Peripheral Neuritis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Peripheral Neuritis Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Peripheral Neuritis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Peripheral Neuritis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Peripheral Neuritis Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Peripheral Neuritis Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Peripheral Neuritis Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Peripheral Neuritis Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Peripheral Neuritis Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Peripheral Neuritis Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Peripheral Neuritis Treatment Product Offerings
Table 32. Pfizer Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Depomed Company Summary
Table 35. Depomed Peripheral Neuritis Treatment Product Offerings
Table 36. Depomed Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Depomed Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Peripheral Neuritis Treatment Product Offerings
Table 40. Novartis Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Biogen Company Summary
Table 43. Biogen Peripheral Neuritis Treatment Product Offerings
Table 44. Biogen Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Biogen Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Peripheral Neuritis Treatment Product Offerings
Table 48. GlaxoSmithKline Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Peripheral Neuritis Treatment Product Offerings
Table 52. Sanofi Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Eli Lilly and Company Company Summary
Table 55. Eli Lilly and Company Peripheral Neuritis Treatment Product Offerings
Table 56. Eli Lilly and Company Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Eli Lilly and Company Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Peripheral Neuritis Treatment Product Offerings
Table 60. Bristol-Myers Squibb Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Baxter Healthcare Company Summary
Table 63. Baxter Healthcare Peripheral Neuritis Treatment Product Offerings
Table 64. Baxter Healthcare Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Baxter Healthcare Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Peripheral Neuritis Treatment Product Offerings
Table 68. Johnson & Johnson Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Teva Pharmaceuticals Company Summary
Table 71. Teva Pharmaceuticals Peripheral Neuritis Treatment Product Offerings
Table 72. Teva Pharmaceuticals Peripheral Neuritis Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Teva Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Peripheral Neuritis Treatment Segment by Type in 2022
Figure 2. Peripheral Neuritis Treatment Segment by Application in 2022
Figure 3. Global Peripheral Neuritis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peripheral Neuritis Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Peripheral Neuritis Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peripheral Neuritis Treatment Revenue in 2022
Figure 8. By Type - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Peripheral Neuritis Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Peripheral Neuritis Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 16. US Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 28. China Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Peripheral Neuritis Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Peripheral Neuritis Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Depomed Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biogen Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eli Lilly and Company Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Baxter Healthcare Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Johnson & Johnson Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Teva Pharmaceuticals Peripheral Neuritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
